Skip to main content
. 2022 Jan 24;11:790912. doi: 10.3389/fonc.2021.790912

Figure 1.

Figure 1

FBXO22 expression in human tumors and healthy tissues. (A) FBXO22 expression levels in BLCA, BRCA, COAD, ESCA, HNSC, KICH, KIRC, KIRP, LIHC, LUAD, LUSC, PRAD, READ, STAD, THCA, and UCEC from TCGA database. (B) Analysis of ACC, DLBC, LAML, LGG, OV, TGCT, UCS, SARC, PAAD, GBM, PCPG, THYM, CHOL, CESC, and SKCM in TCGA using GEPIA2; corresponding healthy tissues from the GTEx database were included as controls. (C) Total FBXO22 protein expression levels in healthy and primary breast cancer, lung adenocarcinoma, and UCEC tissue, based on the CPTAC dataset from UALCAN. (D) Total FBXO22 protein levels in human lung cancer and bronchial epithelial cell lines. ns, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001.